Back to search

National Technical University of Athens (NTUA)

Νέα βιοδραστικά ανάλογα φυσικών προϊόντων και μελέτη εγκλεισμού τους σε βιοδιασπώμενα πολυμερή

Abstract

dc:description

The aim of the present doctoral thesis was initially the development of a "bioinspired chemical library" of novel, synthetic analogues of the coumarin family. The structurally modified analogues that showed promising in vitro biological activity were then encapsulated in biodegradable carriers, thus expanding their application potential.In the present work, the design, synthesis and structural characterization of 100 coumarin derivatives was achieved, 80 of which are new in the literature. In particular, four series of coumarin derivatives A, B, C and D were designed. Series A consists of 4-methyl-umbelliferone analogues with hydroxy- or dihydroxy-substitution on the coumarin aromatic ring, which were synthesized via Pechmann condensation reaction using FeCl3 as a catalyst, making the process more environmentally friendly. Structural modifications by alkylation of the hydroxyl groups was undertaken in order to enrich Series A.Series B includes 5-or 7-acetyloxy-, hydroxy- and prenyloxy-derivatives possessing a phenyl-substituent at position 3 of the coumarin lactone ring as a common structural feature. Acetyloxy derivatives were synthesized by a modified Perkin-Oglialoro reaction and then the corresponding 5- or 7-hydroxy-3-phenyl-coumarin analogues were synthesized by removal of the acetyl group using hydrazine monohydrate. The prenyloxy derivatives of series B were obtained via Williamson ether synthesis using prenyl, geranyl- or farnesyl bromide in a basic environment.Series C was designed by combining two pharmacophore structures, namely coumarin and chalcone, leading to the formation of a hybrid coumarin-chalcone structure. The presence of a prenyloxy-substituent at position 7 of the coumarin aromatic ring enhances their novel character. The hybrid molecules bearing prenyloxy-substitution were synthesized in three steps via an optimized aldol condensation reaction. Series D comprises of coumarin-phenolic acid hybrid molecules. Their synthesis was carried out in order to investigate the effect of combining the antioxidant effect of phenolic acids and the activity of natural coumarins umbelliferone and 4-methyl umbelliferone, in biological activity. The desired hybrid molecules were synthesized following the development of a three-step synthesis methodology.The new derivatives were evaluated for their potential antioxidant activity through their ability to interact with free radical DPPH and their ability to inhibit lipid peroxidation (LP). The anti-inflammatory activity of the compounds was evaluated by their ability to inhibit the activity of the soybean lipoxygenase (LOX), an enzyme which in the human body is associated with the production of pro-inflammatory compounds such as leukotrienes.The cytotoxicity of the new coumarins was evaluated via the MTT assay using the human neuroblastoma cell line SK-N-SH, the human cervical epithelioid cell line HeLa, the human lung epithelioid cell line A549 and the breast epithelioid cell line MCF-7. The evaluation provided significant observations for the structure-activity relationship. A number of coumarin derivatives were efficient inhibitors of lipid peroxidation (80-100%) and showed significant LOX inhibitory activity (IC50 of 10-40 μM).A molecular docking simulation for soybean lipoxygenase was performed for the molecule with the best anti-inflammatory activity (IC50 10 μM). The results indicated that the molecule presents allosteric interactions with the enzyme. In addition, selected coumarin derivatives exhibited remarkable cytotoxicity against human neuroblastoma SK-N-SH and HeLa adenocarcinoma cell lines showing IC50 values from 1.8 μM to 13.6 μM. It is noted that three derivatives of Series B bearing a 3-phenyl-substituent with bromo- and methoxy groups as well as acetyl- or farnesyl-substitution exhibited a combined activity.The coumarin derivatives with the best biological activity have been successfully encapsulated in various biodegradable carriers in order to modify their physicochemical properties, such as water solubility, enhance and / or improve their biological activity, reduce undesirable side effects, and allow targeted and controlled release. The nanoparticles were structurally characterized using NMR (1H and 2D NMR) and FT-IR spectroscopy while the size and ζ-potential were determined with dynamic light scattering (DLS). The thermal properties of nanoparticles were studied by DSC and TGA techniques, and their morphology using Scanning Electron Microscopy (SEM) and fluorescence microscopy. Specifically, in the present doctoral thesis the encapsulation of the natural coumarins 4-methyl-umbelliferone and auraptene, as well as of selected derivatives from Series B having significant anti-inflammatory and cytotoxic activity, was performed. The encapsulation of lipophilic compounds from Series B using β-cyclodextrin as encapsulation carrier was successfully accomplished, as indicated by the characterization techniques.4-methyl umbelliferone was encapsulated in three different encapsulation carriers, namely poly (lactic) acid, poly (lactic-glycolic) acid (PLGA) and the oligosaccharide β-cyclodextrin. The size of the formed PLA and PLGA nanoparticles was 200 nm and 165 nm, respectively. The inclusion complex of 4-methyl-umbelliferone in β-cyclodextrin was structurally characterized by different techniques, and the release profile of the encapsulated substance from the β-cyclodextrin cavity was studied.The inclusion complex was then tested in vitro showing a combined antioxidant and anti-inflammatory activity (inhibition of LP: 100%, inhibition of LOX: IC50 10 μM activity while 4-methyl umbelliferone induces LP inhibition: 93% and is inactive against the enzyme) and its incorporation in pharmaceutical tablets was investigatedIn particular, β-cyclodextrin in the complex was one of the excipients while 4-methyl umbelliferone was the Active Pharmaceutical Ingredient (API). In order to determine the excipient proportions in the pharmaceutical tablets, preliminary experiments were initially carried out studying their mechanical properties, followed by Design of Experiments (DoE) (Mixture DoE) in order to determine the number of pharmaceutical tablets and the proportions of the excipients in them.In this doctoral thesis, the development of an appropriate method for the encapsulation of plant extracts and essential oils containing bioactive natural products was also achieved in order to protect them from oxidation and degradation, to increase their water solubility and to allow their controlled release. The bioactive olive leaf extract, Origanum onites L. and Mentha pulegium essential oil (EO) were encapsulated in PLA, β-cyclodextrin (β-CD) and yeast microparticles (Saccharomyces cerevisiae), respectively.The various nanoparticles were characterized using different characterization techniques (1H 1D & 2D NMR, FT-IR, DLS, DSC, TGA and SEM). Moreover, the release profile was studied, and the kinetic modeling of the release was carried out. Mentha pulegium EO was successfully encapsulated in non-toxic yeast cells (Saccharomyces cerevisiae) using a simple methodology based on passive diffusion. The essential oil Mentha pulegium was encapsulated in order to reduce its volatility, to increase its water solubility and to extend its insecticidal activity. Mentha pulegium essential oil and the formed yeast microparticles were evaluated as pesticide against the insect pest Myzus persicae. The evaluation revealed that the encapsulated EO had a stronger incesticidal effect than the non-encapsulated oil 72 h after treatment. This is a promising result indicating that the encapsulation methodologies used can substantially extend the bioactivity of the EO.The encapsulation of olive leaf extract in PLA nanoparticles leads to the formation of nanospheres with mean size of 246.3 nm, as was observed in SEM images. The formed nanoparticles possessed a significant antioxidant activity whereasthe release study revealed a "burst effect” in the first two hours.The inclusion complexes of β-CD with Origanum onites L. EO presented satisfactory size distribution (450 nm) and, as indicated by SEM, non-spherical morphology. SEM analysis also revealed that the β-CD – oregano EO inclusion complexes form agglomerates of different sizes, which is attributable to the tendency of cyclodextrins to agglomerate. The release profile was studied at various temperature and pH conditions following the same trend in all cases.

Degree

thesis:*
Grantor dc:publisher
National Technical University of Athens (NTUA)
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kavetsou, Eleni
  • Καβέτσου, Ελένη

Subjects

dc:subject × 24

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45668

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kavetsou, Eleni; Καβέτσου, Ελένη. Νέα βιοδραστικά ανάλογα φυσικών προϊόντων και μελέτη εγκλεισμού τους σε βιοδιασπώμενα πολυμερή. National Technical University of Athens (NTUA), 2019. http://hdl.handle.net/10442/hedi/45668